The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.
SOSV, established in 1995 and headquartered in Princeton, New Jersey, is a global venture capital firm specializing in early-stage investments. It focuses on deep tech innovations in the health and environmental sectors, supporting founders with breakthrough technologies through its HAX and IndieBio startup development programs. SOSV provides resources, facilities, and lab equipment to accelerate product development and scale, with a track record of helping its portfolio companies secure subsequent funding rounds led by top-tier investors.
MedTech Innovator is a nonprofit global competition and accelerator based in Los Angeles, California, founded in 2013. It focuses on supporting companies in the medical device, digital health, and diagnostic sectors. The organization aims to enhance patient outcomes by fostering the growth of businesses that contribute to the transformation of the healthcare system. Each year, MedTech Innovator showcases 100 companies that align with key themes identified through surveys of industry leaders. The accelerator's diverse portfolio includes firms involved in consumer healthcare, imaging, remote patient monitoring, clinical studies, and workflow optimization, emphasizing its commitment to advancing innovative healthcare solutions.
HAX is a venture capital program focused on accelerating hardware startups through its comprehensive support and resources. Founded in 2012 and headquartered in Newark, New Jersey, HAX operates in two key locations, San Francisco and Shenzhen, providing founders with an environment conducive to rapid prototyping and iterative development. The program emphasizes the importance of launching both B2C and B2B hardware startups, guiding them through critical phases such as business development, fundraising, and market entry. HAX accepts teams that demonstrate strong potential for scaling their ventures and solving significant technological challenges. Through a structured curriculum, entrepreneurs refine their product-market fit and business strategies while benefiting from a robust network of mentors and industry connections. HAX maintains an ongoing relationship with participating startups to support their growth beyond the initial program, ensuring they have the necessary resources and partnerships to succeed in the competitive marketplace.
NeuroOne Medical Technologies Corporation is a medical technology company based in Eden Prairie, Minnesota. It is dedicated to the development and commercialization of advanced thin film electrode technology designed for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording. The company's focus extends to spinal cord stimulation, brain stimulation, and ablation solutions, targeting patients with conditions such as epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain resulting from failed back surgeries. NeuroOne aims to provide minimally invasive, high-definition solutions that enhance patient outcomes while potentially reducing procedural costs in the treatment of various neurological disorders.
Golden Falcon Capital is a venture capital firm established in 2021, located in Wilmington, Delaware. The firm specializes in providing investment services with a focus on technology sectors including software as a service (SaaS), infrastructure software, security, fintech, insurance technology, commerce, artificial intelligence, analytics, and consumer technology. Golden Falcon Capital targets technology companies in the United States, Israel, and emerging markets, aiming to support innovation and growth in these dynamic industries. The firm communicates with potential and current clients through phone and email.
Clearway Pain Solutions Institute, LLC is a pain management medical center founded in 2013 and located in Pensacola, Florida. The institute focuses on relieving pain, restoring function, and enhancing the quality of life for patients through compassionate, patient-centered care. It offers a range of services, including interventional pain management, medication management, regenerative medicine, chiropractic care, massage therapy, and physical therapy. By employing a collaborative approach, Clearway Pain Solutions integrates the expertise of leading physicians, advanced practitioners, chiropractors, physical therapists, and dedicated support staff to empower patients to lead happier and healthier lives.
EMOTIV Inc. is a bioinformatics company based in San Francisco, California, focused on developing brain wearables that enhance the understanding of the human brain through electroencephalography (EEG). The company offers a range of products, including neuroheadsets and wireless EEG devices that record and translate brainwaves, along with software solutions designed to facilitate brain-computer interface applications. EMOTIV's technologies cater to various sectors such as gaming, healthcare, robotics, automotive, and market research. Recognized as a pioneer in its field, EMOTIV has received numerous international awards for its innovative designs and contributions to brain research. Founded in 2011, the company also boasts a global community of developers and researchers, furthering advancements in brain health and cognitive potential through the application of artificial intelligence and machine learning.
Andreessen Horowitz, established in 2009 by Marc Andreessen and Ben Horowitz, is a prominent venture capital firm based in Menlo Park, California. The company specializes in investing in software businesses, with a focus on sectors such as bio + healthcare, artificial intelligence, consumer, enterprise, fintech, and infrastructure. It typically invests in startups at various stages, from seed to late-stage, with a flexible investment range of $0.025 million to $50 million. The firm is known for its focus on disruptive technology and has raised multiple funds to support its investment strategy.
Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.
Seven Seas Partners is a venture capital investment firm based in Menlo Park, California, established in 2014. The firm specializes in investing in early growth and growth-stage companies, primarily focusing on sectors such as consumer and mobile internet, software as a service (SaaS), the Internet of Things, and enterprise cloud infrastructure and services. Seven Seas Partners aims to support innovative enterprises in the United States and Mainland China, leveraging its expertise in high-technology to drive growth and development within these industries.
eHealth Ventures, established in 2014, is an Israeli-based accelerator/incubator firm specializing in digital health. It focuses on investing in and nurturing early-stage companies within the digital therapeutics and diagnostics sectors. The firm leverages significant government funding and backing from prominent venture capital funds and a technological incubator.
Enterprise Ireland is a government agency based in Dublin, Ireland, established in 1998 to foster the growth and development of indigenous businesses. Its primary mission is to assist Irish enterprises in achieving a strong presence in global markets, thereby enhancing national and regional prosperity. The agency supports a wide range of companies, from high-potential start-ups to established businesses, by providing funding, resources, and guidance. Additionally, Enterprise Ireland collaborates with college-based researchers to facilitate the development and commercialization of innovative technologies through licensing and spin-out companies. By focusing on innovation and export sales, Enterprise Ireland plays a crucial role in driving economic growth and competitiveness within the Irish economy.
Lumo Labs is a venture capital investment firm based in Eindhoven, Netherlands, with an additional office in Los Angeles. It operates as both a venture capital firm and a venture builder, focusing on early-stage companies from pre-seed to series A. Lumo Labs invests in ventures that leverage emerging technologies, including artificial intelligence, blockchain, IoT, and VR/AR, to address significant social challenges. The firm emphasizes sectors such as sustainable cities and communities, health and well-being, and quality education. By connecting innovative start-ups with capital, expertise, and a robust network, Lumo Labs aims to create impactful opportunities that drive technological advancement and social improvement.
Verge HealthTech Fund, established in 2018 and based in Singapore, is a venture capital firm focused on early-stage investments in global healthcare technology companies. It targets innovative solutions that address disease prevention, management, and health system efficiency, with a particular relevance to emerging Asian markets. The firm seeks and supports visionary founders creating transformative healthtech companies, aiming to foster their growth and scale, regardless of their origin, from Dhaka's streets to Oxford's labs.
UCB SA, established in 1928, is a Belgium-based biopharmaceutical company that develops and markets therapies for neurology and immunology diseases. Its primary products include Cimzia for inflammatory diseases, Vimpat and Briviact for epilepsy, Neupro for Parkinson's disease and restless legs syndrome, and Nayzilam for seizure clusters. Additionally, UCB offers treatments for allergies, memory problems, narcolepsy, and osteoporosis. The company is also involved in developing novel therapies for conditions like myasthenia gravis, drug-resistant epilepsy, and systemic lupus erythematosus. UCB engages in research and development activities in neurology, immunology, and other areas, and has collaboration agreements with several pharmaceutical companies.
WI Harper Group, established in 1993, is a venture capital firm headquartered in San Francisco with offices in Beijing and Taipei. It specializes in early and early expansion investments, primarily in Mainland China, Taiwan, and Silicon Valley. The firm manages multiple funds totaling over $1 billion and has a team of 19 dedicated investment professionals. WI Harper Group focuses on technology, clean technology, and healthcare sectors, with a notable track record including investments in DivX, Focus Media, Vizio, SiRF, and Commerce One.
Osaka University Venture Capital is a venture capital firm established in 2014, serving as the investment arm of Osaka University in Japan. The firm specializes in early-stage ventures and focuses on sectors such as healthcare, life science, artificial intelligence, machine learning, big data, and innovations in life and green technology. With a preference for minority seed and early-stage investments, Osaka University Venture Capital aims to support the development of innovative solutions within these fields, contributing to advancements that align with the university's mission of fostering research and entrepreneurship.
Techstart Ventures is a venture capital firm based in Belfast, Northern Ireland, founded in 2014. The firm specializes in early-stage investments, focusing primarily on the information technology sector. Techstart Ventures aims to support exceptional founders who are pursuing significant global opportunities, primarily targeting companies in Scotland and Northern Ireland. Through its investments, the firm seeks to foster innovation and growth within the technology landscape of these regions.
Clarendon Fund Managers Limited is a venture capital firm based in Belfast, Northern Ireland, that specializes in investing in small and medium enterprises across various sectors. Established in 2001, the firm focuses primarily on manufacturing and tradable services, preferring to support companies located in Northern Ireland. Clarendon typically invests between £20,000 and £250,000 in initial funding and is open to providing additional financing as needed. The firm has a strategic goal of exiting its investments within five to seven years. Clarendon manages regional venture capital funds, including a significant co-investment fund, and has a robust track record, having invested in over 60 companies since its inception.
The National Institutes of Health (NIH) is a leading biomedical research facility in the United States, operating under the Department of Health and Human Services. Established in 1887 and based in Bethesda, Maryland, NIH is the primary agency responsible for biomedical and health-related research in the country. It comprises 27 separate institutes and centers, each focusing on different disciplines within biomedical science. NIH conducts its own scientific research through the Intramural Research Program and provides significant funding for research at external institutions via the Extramural Research Program. With a workforce that includes 1,200 principal investigators and over 4,000 postdoctoral fellows, NIH has been instrumental in major medical breakthroughs, such as the development of vaccines for hepatitis and human papillomavirus, as well as the discovery of treatments for various health conditions. As the world's largest source of medical research funding, NIH continues to advance scientific knowledge and contribute to public health improvements.
MassChallenge is a global nonprofit startup accelerator headquartered in Boston, Massachusetts, established in 2009. It supports early-stage entrepreneurs across various industries, including technology, healthcare, and social impact, by providing mentorship, resources, and networking opportunities. With locations in Israel, Mexico, Switzerland, Texas, and the UK, MassChallenge connects high-potential startups with industry experts and investors to foster innovation and facilitate growth. The accelerator operates on a non-equity model, allowing entrepreneurs to maintain full ownership of their companies while benefiting from strategic partnerships and tailored training programs. Through its diverse initiatives, such as targeted accelerator programs like MassChallenge HealthTech and FinTech, the organization aims to drive impactful change and enhance the global innovation ecosystem.
Graham Partners, established in 1988, is a private equity investment firm headquartered in Newtown Square, Pennsylvania. The firm, with roots tracing back to a successful family industrial concern, manages four private equity funds totaling approximately $1.6 billion. Graham Partners invests in growth-oriented companies across various sectors, including industrial technology, software, medical devices and life sciences, consumer and food manufacturing, and advanced manufacturing, primarily in the United States and Canada. The firm focuses on acquiring businesses and supporting their growth through operational improvements and strategic initiatives.
Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.
Elevate Capital, established in 2016, is a venture capital firm headquartered in Hillsboro, Oregon, with an additional office in Portland. The company specializes in investing in early-stage technology and tech-enabled businesses, with a focus on the Pacific Northwest region, particularly the Portland Oregon Metro area and Willamette Valley. Elevate Capital targets minority investments in startups, early-stage, and bridge rounds, with typical investment sizes ranging from $0.03 million to $0.5 million. The firm's portfolio spans various sectors, including SaaS, consumer packaged goods, life science, and technology, among others. Elevate Capital is committed to diversity and inclusion, maintaining a 50/50 male/female founder split and ensuring that at least one co-founder in each investment is from a minority group.
Life Science Angels, Inc. is a prominent angel investment group based in Sunnyvale, California, established in 2005. The organization specializes exclusively in healthcare investments, targeting sectors such as medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health. Life Science Angels focuses on companies at various stages of development, including seed-stage, early-stage, and later-stage ventures. Through its investments, the group aims to support innovation and growth within the healthcare and life sciences industries.
ah! Ventures is a venture capital firm based in Mumbai, India, established in 2010. It serves as a curated, sector-agnostic fundraising platform for early-stage startups seeking up to 10 million USD. The firm boasts a robust network of over 3,000 investors, including more than 2,000 angel investors and 1,000 institutional investors and family offices. With a strong deal pipeline, ah! Ventures assesses over 600 business plans each month. The organization has built a well-established brand as one of India’s premier aggregators, offering a wide range of services to support startup growth across various sectors, including technology, manufacturing, mobile, and TMT.
Thiel Capital, established in 2011, is a venture capital firm based in West Hollywood, California. It focuses on investments across various industries, including artificial intelligence, drones, and healthcare, at seed, early, and later stages. The firm provides strategic and operational support for Peter Thiel's diverse investment initiatives and entrepreneurial ventures.
Berkeley SkyDeck is a global startup accelerator affiliated with UC Berkeley, founded in 2012 and based in Berkeley, California. It offers a six-month cohort program, providing up to $100,000 in funding to accepted startups, with no industry restrictions. The accelerator offers mentorship, access to a vast network of advisors, industry partners, and alumni, and supports around 20 companies per cohort. Additionally, SkyDeck has a dedicated European fund, investing up to €145,000 in selected European startups.
The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.
Atlantic Bridge, established in 2004, is a growth equity firm headquartered in Dublin with offices across Europe and the US. It invests in early-stage, deep technology companies in sectors such as cybersecurity, cloud, enterprise software, and health technology, primarily in the US, Europe, and Ireland. The firm's strategy focuses on partnering with ambitious entrepreneurs and management teams, providing capital and leveraging its global platform to facilitate international expansion. Atlantic Bridge's team comprises experienced entrepreneurs, technology industry executives, and investment professionals, offering a unique blend of international business experience and a collaborative approach to investing.
Furthr VC, founded in 1990 and based in Dublin, Ireland, is a venture capital firm focused on early-stage investments in ambitious software and medtech companies. The firm targets Seed to Series A funding rounds, forming close partnerships with founders to support their growth. Furthr VC takes a hands-on approach, assisting teams in key strategic areas to accelerate their development. In addition to providing initial capital, the firm allocates significant resources for follow-on investments in subsequent funding rounds, ensuring that it remains engaged throughout the founders' journey.
Desjardins Group, established in 1900, is a cooperative financial group based in Montreal, Canada. It offers a wide range of financial services to individuals and businesses, including personal banking, credit and loans, investments, insurance, and wealth management. Through its subsidiary, Desjardins Capital, the group provides venture capital and development capital to businesses and cooperatives across various sectors such as healthcare, manufacturing, technology, and agriculture. Desjardins Capital invests in startups, early-stage, and mature companies, typically providing equity or debt financing ranging from $0.09 million to $20 million for periods of 3 to 10 years. The group also offers corporate financing, debt capital markets, and equity capital markets services through its Desjardins Securities division.
Jolt Capital, established in 2011 and headquartered in Paris, France, is a private equity firm specializing in growth equity investments. It focuses on mid-sized European technology companies, typically with revenues between €10 million and €100 million and maximum EBITDA of €40 million. Jolt Capital invests in these companies to finance working capital, capital expenditures, external growth strategies, and to strengthen their balance sheets. Its investment range is between €5 million and €40 million, with a preference for leading equity positions that may include a board seat or minority stakes. The firm's portfolio spans various technology sectors, including software, hardware, mobility, cloud, IoT, cybersecurity, and digital health, among others. Jolt Capital is led by Jean Schmitt and an experienced team, aiming to catalyze growth and operational efficiency in its portfolio companies.
Holland Capital, established in 1981, is a Dutch private equity firm headquartered in Amsterdam. It specializes in early-stage investments, primarily in the healthcare and technology sectors. The firm manages two active funds: one dedicated to supporting the growth of small and medium-sized enterprises (SMEs) in the Netherlands, and another focused on innovative healthcare businesses. Since its inception, Holland Capital has successfully realized over 115 investments.
Utrecht Health Seed Fund is a venture capital firm established in 2020 and located in Utrecht, Netherlands. It is a collaborative initiative between Utrecht Holdings and the Economic Board Utrecht. The firm focuses on investing in start-ups and seed-stage companies within the life sciences sectors, including biotechnology, pharmaceuticals, diagnostics, as well as digital health, medical devices, and animal health. Utrecht Health Seed Fund typically invests between €100,000 and €250,000, primarily through convertible loans or equity, and prefers to engage in partnerships with co-investors to enhance its investment strategy.
Par Equity, established in 2008, is a venture capital firm headquartered in Edinburgh, Scotland. It specializes in investing in early-stage, high-growth technology companies based in Northern England, Northern Ireland, and Scotland.
Sunstone Management, Inc. is a venture capital and private equity firm founded in 2015, based in Irvine, California. The firm specializes in growth capital and focuses on small and lower middle market investments, primarily in the technology and services sectors. Sunstone Management is dedicated to providing comprehensive wealth management solutions for high net worth clients worldwide. The firm invests in early-stage technology companies and typically targets U.S.-based investments, offering a range of investment strategies that include short-term senior debt, equity, and venture capital options to meet the diverse goals of its investors.
Bullnet Capital, established in 2001, is a Madrid-based venture capital firm specializing in early-stage investments. It focuses on technology-oriented projects, particularly in software, hardware, and high-value-added services, with a primary focus on companies based in Spain. The firm typically invests between €1 million and €2.5 million per round, with flexibility to consider smaller or larger rounds, and often co-invests in larger projects. Bullnet Capital has a strong track record in the healthcare sector and is open to investments in other technology sectors, aiming to support around 15 companies per fund.
The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease. Our pioneering biomedical venture philanthropy approach allows us to invest in the most promising drug discovery and development programs around the world in both academic institutions and biopharmaceutical companies. Since our founding in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.
Joyance Partners, established in 2012 and headquartered in San Francisco, is a venture capital firm focusing on early-stage investments. It specializes in startups and emerging technologies that empower individuals to improve their health and well-being, with a particular interest in health tech and consumer sectors. The firm invests in companies that leverage science and technology to cultivate joy and enhance lives, targeting pre-seed to Series A rounds in the United States, Canada, and Europe.
Venture Kick is a private philanthropic initiative based in Zurich, Switzerland, founded in 2007 to support Swiss startups at the pre-seed stage. It provides up to 150,000 Swiss francs in funding and offers structured entrepreneurial training aimed at developing sustainable businesses. Entrepreneurs participate in a competitive process, pitching their ideas up to three times for increasing funding amounts, while receiving valuable feedback from expert juries. To date, Venture Kick has supported 600 startup projects with a total of 24.9 million francs, leading to the incorporation of 454 active companies that have created over 6,000 jobs and attracted approximately 2.49 billion francs in subsequent investments. Companies founded by Venture Kick alumni have notably achieved significant recognition, with 55 percent of the TOP 100 Swiss Startup Award in 2018 represented by these ventures. In 2019, the initiative aimed to allocate 4.35 million francs to support idea-stage projects, facilitating the transition of Swiss scientific innovations to global markets.
SIG China operates through SIG Asia Investments, a wholly foreign-owned enterprise based in Shanghai with an office in Beijing. The firm focuses on venture capital and private equity investments within China, aiming to deploy proprietary capital in companies operating in the region. As part of the larger Susquehanna International Group, which has over two decades of experience in financial services, SIG China benefits from a robust foundation in trading, market making, and institutional research. The team emphasizes an entrepreneurial approach, leveraging advanced technology and quantitative research to identify and develop investment opportunities. With a commitment to expanding its business in China, SIG Asia Investments plays a pivotal role in fostering growth within the local investment landscape.
GoArmy is dedicated to fulfilling the mission of the United States Army, which centers on achieving and maintaining land dominance in various military operations. The organization adheres to Title 10 and Title 32 of the United States Code, focusing on the organization, equipping, and training of forces to ensure their readiness for prompt and sustained combat operations. GoArmy plays a critical role in executing missions assigned by the President, the Secretary of Defense, and combatant commanders, while also emphasizing the importance of transformation for future military effectiveness. Through these efforts, GoArmy supports the overarching goal of winning the Nation's wars and ensuring national security.
ShangBay Capital, established in 2015 and based in Palo Alto, California, is a venture capital firm specializing in early-stage investments. It focuses on U.S.-based healthcare technology companies, with a particular interest in medical devices, biotechnology, and mobile healthcare sectors. As a Registered Investment Adviser, the firm aims to support innovative startups in these areas.
The Ontario Brain Institute, established in 2010 and based in Toronto, is a provincially-funded, not-for-profit research center dedicated to advancing neuroscience. Its mission is to position Ontario as a global leader in brain research, commercialization, and care. The Institute fosters collaborations among researchers, clinicians, industry stakeholders, patients, and their advocates to drive innovation and develop products and services aimed at improving the lives of individuals affected by brain disorders. By providing grants and financing to companies in the neurotechnology sector across Canada, the Ontario Brain Institute seeks to maximize the impact of neuroscience and enhance the overall landscape of brain health and treatment.
D.CAMP, established on March 27, 2013, in the Gangnam area of Seoul by the Banks Foundation for Young Entrepreneurs, operates as a local startup hub dedicated to fostering entrepreneurship. Spanning 45,000 square feet, D.CAMP offers a range of facilities including co-working spaces, lounges, private offices, and venues for lectures and events, catering to talented startup entrepreneurs and professionals. The Banks Foundation for Young Entrepreneurs, a non-profit organization formed in 2012 by twenty South Korean banks, aims to support youth entrepreneurship and combat rising youth unemployment by reinvesting a portion of the banks' profits into the community. Through D.CAMP, the foundation provides essential resources and support for startups, both financially and through various other means.
TheVentures, established in 2014 and headquartered in Seoul, South Korea, is a venture capital firm that invests in early-stage technology companies across East and Southeast Asia. The company offers its portfolio a range of operational support, including expert guidance in recruiting, public relations, marketing, customer acquisition, fundraising, and strategic planning. Additionally, TheVentures provides technical assistance, collaborating with founding teams to build products and helping recruit early-stage engineers.
ACF Investors, established in 2011 and based in Sheffield, United Kingdom, operates as a venture capital entity that collaborates with experienced angel investors to support early-stage businesses. The firm focuses on co-investing alongside syndicates of angel investors, leveraging their sector-specific expertise to identify and fund high-potential companies. ACF Investors has built a strong portfolio, having invested over £40 million in partnership with more than £200 million from angel investors and other sources, resulting in a diverse collection of over 80 companies. The organization is dedicated to fostering the growth of small and medium-sized enterprises throughout the UK, often providing support through multiple funding rounds as these companies scale.